Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MP-Myeloma Regimen

Known as: Melphalan-Prednisone Regimen 
A regimen consisting of melphalan and prednisone used as induction treatment for multiple myeloma.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
This phase I/II dose-escalation study investigated the all-oral ixazomib-melphalan-prednisone regimen, followed by single-agent… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2016
Review
2016
Multiple myeloma (MM) is a disease of the elderly, with a median age at diagnosis of approximately 70 years old, and more than 30… Expand
Is this relevant?
2014
2014
Substantial efficacy has been demonstrated with bortezomib-melphalan-prednisone in phase III studies in transplant-ineligible… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2014
2014
Multiple myeloma is a plasma cell disorder characterized by malignant plasma cell infiltration in the bone marrow, serum and/or… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2014
2014
Multiple Myeloma is a plasma cell disorder, characterized by malignant plasma cell infiltration in the bone marrow, serum and/or… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
Review
2013
Review
2013
In recent years, the treatment of multiple myeloma has undergone significant changes. The availability of novel agents bortezomib… Expand
  • table 1
  • table 2
Is this relevant?
Review
2007
Review
2007
The melphalan-prednisone regimen has been considered as standard therapy for patients with multiple myeloma (MM) for many years… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 4
Is this relevant?
Review
2006
Review
2006
Thalidomide was introduced in the treatment of multiple myeloma in the late 1990s. Following the initial results, which… Expand
Is this relevant?
2002
2002
Until 1990, the melphalan-prednisone regimen was the standard treatment for multiple myeloma (MM). The role of alpha-interferon… Expand
Is this relevant?